OIRA Conclusion of EO 12866 Regulatory Review

RIN: 0910-ZB46         View EO 12866 Meetings	Received Date: 01/24/2023
Title: Protein Efficiency Ratio Rat Bioassay Studies To Demonstrate That a New Infant Formula Supports the Quality Factor of Sufficient Biological Quality of Protein; Draft Guidance for Industry
Agency/Subagency: HHS / FDA	Stage: Notice
Concluded Action: Consistent with Change	Concluded Date: 02/01/2023
Legal Deadline: None	Economically Significant: No
Publication Date:	Unfunded Mandates: No
Major: No	Related To Homeland Security: No
Regulatory Flexibility Analysis Required: Undetermined	Small Entities Affected:
Federalism Implications: No	Affordable Care Act [Pub. L. 111-148 & 111-152]: No
International Impacts: No	Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]: No
Pandemic Response: No